Malin Fageras

Biopharma R&D
Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Tozorakimab to Prevent COPD Exacerbations.

Tozorakimab to Prevent COPD Exacerbations.

Journal: The New England journal of medicine

Published: September 08, 2026

Global Viral Lower Respiratory Disease Episodes, Hospitalisations, and Clinical Outcomes by Aetiology, 2010-2021.

Global Viral Lower Respiratory Disease Episodes, Hospitalisations, and Clinical Outcomes by Aetiology, 2010-2021.

Journal: Infectious diseases and therapy

Published: April 27, 2026

Phase III LUNA clinical programme: design of four randomised, double-blind, placebo-controlled studies assessing the efficacy and safety of tozorakimab in patients with symptomatic COPD and a high risk of exacerbations.

Phase III LUNA clinical programme: design of four randomised, double-blind, placebo-controlled studies assessing the efficacy and safety of tozorakimab in patients with symptomatic COPD and a high risk of exacerbations.

Journal: BMJ open respiratory research

Published: February 23, 2026

Clinical Burden of People with Symptomatic and Exacerbating COPD While on Triple Inhaled Therapy.

Clinical Burden of People with Symptomatic and Exacerbating COPD While on Triple Inhaled Therapy.

Journal: Journal of clinical medicine

Published: July 31, 2025

Current Smoking and Pharmacological Treatment Responses in Chronic Obstructive Pulmonary Disease: Not Clear-Cut.

Current Smoking and Pharmacological Treatment Responses in Chronic Obstructive Pulmonary Disease: Not Clear-Cut.

Journal: American journal of respiratory and critical care medicine

Published: July 18, 2025

Clinical outcomes and costs associated with viral lower respiratory tract disease hospitalisations.

Clinical outcomes and costs associated with viral lower respiratory tract disease hospitalisations.

Journal: BMJ open respiratory research

Published: June 24, 2025

Characteristics and Outcomes of People With COPD Who Experience Exacerbations While on Inhaled Triple Therapy: Results of the SIRIUS I Cohort Study in the US (2015-2019).

Characteristics and Outcomes of People With COPD Who Experience Exacerbations While on Inhaled Triple Therapy: Results of the SIRIUS I Cohort Study in the US (2015-2019).

Journal: International journal of chronic obstructive pulmonary disease

Published: January 10, 2025

Exploring Definitions and Predictors of Severe Asthma Clinical Remission after Biologic Treatment in Adults.

Exploring Definitions and Predictors of Severe Asthma Clinical Remission after Biologic Treatment in Adults.

Journal: American journal of respiratory and critical care medicine

Published: May 03, 2024

Structural Predictors of Lung Function Decline in Young Smokers with Normal Spirometry.

Structural Predictors of Lung Function Decline in Young Smokers with Normal Spirometry.

Journal: American journal of respiratory and critical care medicine

Published: January 04, 2024

Use of CompEx in eosinophilic patients with severe, uncontrolled asthma on benralizumab.

Use of CompEx in eosinophilic patients with severe, uncontrolled asthma on benralizumab.

Journal: ERJ open research

Published: December 19, 2023

Exploring Definitions and Predictors of Response to Biologics for Severe Asthma.

Exploring Definitions and Predictors of Response to Biologics for Severe Asthma.

Journal: The journal of allergy and clinical immunology. In practice

Published: December 04, 2023

Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum.

Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum.

Journal: The journal of allergy and clinical immunology. In practice

Published: December 15, 2022

Showing 1-12 of 33

Last Updated: 09/26/2026